Lv3
340 积分 2026-01-15 加入
Validation of a scoring algorithm for the clinician-reported outcome tool ‘prurigo activity and severity (PAS)’ based on clinical studies of dupilumab in adults with prurigo Nodularis
7个月前
已完结
Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life
7个月前
已完结
Validation of a scoring algorithm for the clinician-reported outcome tool 'prurigo activity and severity (PAS)' based on clinical studies of dupilumab in adults with prurigo Nodularis
7个月前
已完结
Prurigo Activity Score (PAS): Validity and Reliability of a New Instrument to Monitor Chronic Prurigo
7个月前
已完结
[Assessment of pruritus - current standards and implications for clinical practice : consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)]
7个月前
已完结
Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial
7个月前
已完结
Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo
7个月前
已完结
皖公网安备34019202002308
